TAG
PRNewswire
AnotherBall, the Company Behind IZUMO, Secures $12.7M in Seed Funding, Surpassing $14.8M in Total Funding
Strengthening the Commitment to Launching the VTuber Platform SINGAPORE, Nov. 27, 2023 /PRNewswire/ -- AnotherBall (CEO: Shunsuke Oyu, also known as Captain), an entertainment...
Brown 's stories with China
BEIJING, Nov. 27, 2023 /PRNewswire/ -- A news report from China.org.cn on Brown 's stories with China: ...
SMARTKEM, INC. CHIEF TECHNOLOGY OFFICER, DR. SIMON OGIER, TO GIVE LIVE PRESENTATION AT TECHBLICK MINI- AND MICRO-LED DISPLAYS CONFERENCE
MANCHESTER, England, Nov. 27, 2023 /PRNewswire/ -- SmartKem, Inc. (OTCQB: SMTK), a company seeking to reshape the world of electronics with its disruptive organic...
Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Met Primary Endpoint of Progression-Free Survival in Phase III Trial for First-Line Treatment of Recurrent/Metastatic Cervical Cancer in All-Comer Patients
HONG KONG, Nov. 27, 2023 /PRNewswire/ -- Akeso (9926. HK) has announced that the AK104-303 Phase III trial, which investigated cadonilimab (Akeso's PD-1/CTLA-4 bispecific antibody)...
